SBFM - Sunshine Biopharma Quarterly EPS earnings growth
Sunshine Biopharma develops targeted drugs for the therapy of severe oncological forms, ensuring high margins. Analyzing the quarterly net income per share dynamics on GURU.Markets, we find that the indicator stands at 87.20. Sunshine Biopharma balances its budget through the sale of generics and scientific research. Amid intense competition for oral medications, the issuer is actively developing strategic partnerships.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_SBFM_-_Sunshine-Biopharma_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "Sunshine Biopharma, Inc. (SBFM): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/15/2026 | 👁️GURU.Markets👁️")
Comprehensive metric breakdowns and analytics for sunshinebiopharma.com (SBFM)
- market value and analyst target forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Debt to Equity Sunshine Biopharma|SBFM - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity sunshinebiopharma.com|SBFM - Company Total Debt Obligations|Debts to Book Capitalization Sunshine Biopharma, Inc.|SBFM - Company Long-Term Loans and Borrowings|Company Short-Term Debts Sunshine Biopharma|Quick Liquidity sunshinebiopharma.com
- earnings and market multiples details:
SBFM - Company Profit|Projected Future Earnings Sunshine Biopharma|SBFM - Market Cap to Earnings|Projected Price to Earnings Sunshine Biopharma, Inc.|SBFM - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Sunshine Biopharma|SBFM - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Sunshine Biopharma|SBFM - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months sunshinebiopharma.com|SBFM - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Sunshine Biopharma
- sales and revenue data:
Analysis of all company metrics:Sunshine Biopharma, Inc. - SBFM
Professional managers utilize earnings per share dynamics to assess capital resilience against inflationary risks and verify the real profitability of a business. For Sunshine Biopharma (SBFM), which focuses on clinical trials and bio-waste utilization, the recorded quarterly EPS growth reflects efficient cost management during the drug development stage, allowing investors to differentiate temporary spikes from long-term financial trends.
Who Sunshine Biopharma competes with
ONC: Quarterly EPS earnings growth|Halozyme Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (Revolution Medicines Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Group AAPG|Quarterly EPS earnings growth CGON|Quarterly EPS earnings growth UroGen Pharma Ltd (URGN)|Quarterly EPS earnings growth BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Earnings per share growth in annualized terms for the last twelve months|Erasca Oncology - Quarterly EPS earnings growth|DCTH: Year-over-year earnings per share growth for the last twelve months|YMAB: Quarterly EPS earnings growth|Aura Bio (AURA) - Quarterly EPS earnings growth|CADL (Candel Therapeutics Inc.) - Quarterly EPS earnings growth|ARAY: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SLS (SELLAS Life Sciences Group, Inc.)|Year-over-year earnings per share growth rate for the last twelve months ACTU|Citius Oncology - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HURA|TARA: Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Fate Pharma|Aadi Bioscience Inc (WHWK) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months TScan (TCRX)|Year-over-year net earnings per share growth for the last 12 months CSBR|xbiotech.com (XBIT) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months cel-sci.com (CVM)|OSTX - Earnings per share growth in annualized terms for the last twelve months|Radiopharm Theranostics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ARTV|ANL - Year-over-year earnings per share growth for the last twelve months|VERU - Quarterly EPS earnings growth|Tempest Therapeutics, Inc. (TPST) - Year-over-year earnings per share growth for the last twelve months|XLO: Year-over-year earnings per share growth rate for the last twelve months|RENB (Renovaro Biosciences) - Quarterly EPS earnings growth|MURA: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KAPA (Kairos Pharma Ltd)|Year-over-year earnings per share growth rate for the last twelve months OKUR|CytoMed Therapeutics Limited - Year-over-year net earnings per share growth for the last 12 months|CRIS: Year-over-year earnings per share growth for the last 12 months|APLM - Year-over-year earnings per share growth for the last twelve months|THAR - Quarterly EPS earnings growth|ADVB: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months XBIO (Xenetic Biosciences)|Quarterly EPS earnings growth SLRX|Purple Biotech - Year-over-year earnings per share growth for the last 12 months|American Oncology Network - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months BGNE|CKPT - Year-over-year earnings per share growth for the last twelve months|Elevation Oncology (ELEV) - Year-over-year net earnings per share growth for the last 12 months|ICAD: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Ikena Oncology Inc.|NTBL (Notable Labs Ltd) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Viracta Therapeutics (VIRX)|Year-over-year earnings per share growth for the last twelve months MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth AAPGV (Ascentage)
